Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc. (PLX) is a publicly traded company in the Unknown sector. Across all available filings, 27 corporate insiders have executed 507 transactions totaling $79.5M, demonstrating a bearish sentiment with -$69.5M in net insider flow. The most recent transaction on Dec 19, 2025 involved a purchase of 56,000 shares valued at $101.4K.
PLX Insider Activity Summary
Who Is Buying PLX Stock?
No significant insider buying has been recorded for PLX in the recent period.
Who Is Selling PLX Stock?
No significant insider selling has been recorded for PLX in the recent period.
Is Protalix BioTherapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PLX is bearish with an Insider Alignment Score of 6/100 and a net flow of -$69.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PLX Frequently Asked Questions
Understanding PLX Insider Activity
Insider trading at Protalix BioTherapeutics, Inc. (PLX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 27 insiders are actively trading PLX stock, having executed 507 transactions in the past 90 days. The most active insider is Eli Hurvitz (Executive), who has made 5 transactions totaling $13.9M.
Related Tools
Track Protalix BioTherapeutics, Inc. Insider Activity
Get notified when executives and directors at PLX file new Form 4 transactions